Leu~-enkeph~in), survived the fixation procedure, and were found to be colocalized throu~out the brain. We have observed complex associations between these binding sites and one, two, or all three opioid peptide systems (i.e., proopiomelan~o~in, proenkeph~in, and pr~yno~hin) in different brain regions. These muItiple opioid peptide-receptor subtype associations are apparent, for example, in neural systems involved in the processing of pain stimuli, and may be important for mediating different types of analgesia. Since differential processing of proenkephalin and prodynorphin can give rise to opioids of varying receptor selectivities, the colocalization of opioid receptor subtypes may signify that such processing is a key regulatory event in determining which receptor subtype is activated and, thus. the physiological consequences of opioid neurotransmission.
THE existence of three precursors for opioid peptides has been clearly established by molecufar biological studies [8, 16, 24, 45, [51] [52] [53] 62 , 631. These precursors are: (I) proopiomeianoco~in (F'OMC), which gives rise to p-endorphin and its NH,-terminally acetylated and/or COOH-terminally cleaved forms; (2) proenkephalin, which contains four copies of Met-enkephalin and single copies of Leu-enkephalin, Met-enkephahn-Arg6-Phe', and Met~nkephaIin-Arg~-Gly7-LeuH~ and gives rise to extended enkephahn peptides such as BAM-22P; and (3) prodynorphin, which gives rise to ff-/~-Leo-endo~hin, dyno~hin A, and dynorphin B, ah of which contain the Leu-enkephahn sequence at the NH, terminus. The peptides derived from these three precursors are contained within three distinct sets of neural systems, as determined by numerous immunocytochemical studies (see 11, 28, 37, 751 for reviews). Although the precursors are neuronally segregated, the enkephalin and dynorphin systems, in particular, exhibit substantial anatomical contiguities in many brain regions [ 17, 25, 30, 48, 771 . Given the anatomical complexity and biochemical relatedness of the muhiple opioid systems, it seems worth considering how the "messages" of these systems are differentiated at the receptor level. Despite a wealth of pharmacological and biochemical evidence for the existence of multiple opioid receptors (see [64] for review), the relationship of these receptors to multiple opioid systems is poorly understood. Nevertheless, pharmacological studies of the endogenous ligands have provided some rationale for making anatomical predictions of ligand-receptor associations. While the pentapeptide enkeph~ins appear to bind preferentially to the 6 opioid receptor subtype [44] , prodynorphin-related peptides are usually reported to exhibit selectivity for the K receptor subtype 17, 9, 57, St]. In contrast, p-endorphin binds equally well to the F and 6 opioid receptor subtypes f44], but not to the K subtype [34,573. To begin to explore whether in vitro li8~d-receptor associations predicted anatomical relationships in situ, we found that it was possible to carry out opioid immun~yt~hemical and'receptor autoradjo~phic studies on adjacent sections from formaldehyde-perfused rat brain [38] . This initial study revealed an association, in many brain areas, between Leu-enkephaiin, a putative 8 ligand, and [:SH]naloxone binding sites, which appear to correspond to ~1 opioid receptors under the conditions used. Further studies pointed to a complex relationship between [JHjnaloxone binding sites and all three opioid systems in rat brain (401, a finding also obtained in preliminary studies of rhesus monkey brain (391, In the present report, we extend the study of rhesus monkey brain to describe the relationship between the multiple opioid peptide systems and apparent cr_ and K opioid receptors. LIST were anesthetized with sodium pentobarbital (30 mg/kg, IV), respirated through an endotrachial tube, and perfused through the aorta with 2 liters of saline followed by 16 liters of 0.1 M phosphate-buffer 4% formaldehyde. Some animals were treated, under anesthesia, with coichicine (l-3 mg intracerebroventricuiarly) 48 hours prior to perfusion. Following perfusion, the head was severed from the trunk, placed in a stereotaxic apparatus, and the top of the calvarium was removed. Within the skull, the brain was cut into 1 cm thick slices in the frontal or parasagital planes using a Kopf stereotaxic device with blades attached. The brain slices were removed from the skull, postfixed in buffered 4% formaldehyde for 2-4 hours at 4"C, and then transferred into 15% sucrose in 0.02 M phosphate-buffered saline (PBS) for overnight incubation at 4°C. The tissues were then frozen by immersion into isopentane at -50°C followed by encasement in pulverized dry ice, and stored in a freezer at -80°C. The frozen tissue blocks were sectioned at 20 pm in a Bright cryostat, and the sections were thaw-mounted onto subbed slides and stored in a freezer at -80°C.
Immunocytochemistty
Sections to be processed for immunocytochemistry were air-dried at room temperature and incubated at 37°C with normal goat serum (NGS, from GIBCO) at a dilution of l/30 for 10 minutes, followed by primary rabbit antisera (diluted with PBS containing 0.3% Triton X-100) against ACTH (to label PGMC neurons), Leu-enkephalin, or dynorphin B(l-13) for one hour at 37°C and overnight at 4°C. Control sections were incubated with primary antiserum preabsorbed with l-20 PM concentrations of peptide against which the antiserum was raised, as well as with other peptides with amino acid sequences in common with the original peptide. For these cross-blocking studies, the primary antisera were preabsorbed with Leu-enkephaiin, BAM-22P, dynorphin B(l-13), dynorphin A(l-17), /3-endorphin and ACTH (see [26, 27, for antisera characteristics). The next day, the sections were washed in PBS (3 x 10 minutes) and incubated with NGS for 10 minutes at 37°C followed by goat antirabbit serum (Amei) at l/100 dilution for 30 minutes at 37°C and overnight at 4°C. On the third day, the sections were washed in PBS and incubated with NGS for 10 minutes at 37"C, followed by anti-horseradish peroxidase (anti-HRP) serum at l/200 dilution for 40 minutes at 37°C. The sections were again washed with PBS and incubated with PBS containing 4 &ml HRP enzyme (Sigma, Type VI) for 40 minutes at 37°C. The peroxidase reaction was carried out by incubat@g the sections in PBS containing 0.03% H,O, and 0.125 mg/ml diaminobenzidine (Sigma) for 15 minutes at room temperature with constant stirring. The reacted sections were washed in distilled water (3 x 10 minutes), briefly osmicated (2% OsOJ, washed, dehydrated through ascending concentrations of ethanol and exyienes, and coverslipped in Permount.
Receptor Autoradiography
Sections adjacent or near to those processed for immunocytochemistry were processed for opioid receptor autoradiography [21,22,38-40,421.
In rhesus monkey cerebral cortex, [3H] Nonspecific binding was determined by adding I-10 w.M levorphanol (for g and 6 binding) or UM-1071 (for K binding) to the incubation media for some sections, and then measuring the bound radioactivity to elution into scintillation fluid (Safety-Solve; Research Products Int. Corp.) followed by liquid scintillation counting. Other sections prepared for nonspecific binding were saved for autoradiography.
The slide-mounted sections were processed for autoradiography using one of two methods. Some slides were arranged in X-ray cassettes (Spectroline) and exposed to tritium-sensitive film (E"H]Ultrofilm, LKB) for 8-16 weeks. The film was developed in D-19 (Kodak) for 4 minutes at 19"C, washed in 2% acetic acid for 30 seconds, fixed in Rapidfix (Kodak) for 5 minutes, rinsed in water for 20 minutes, dried, and then photographed using an enlarger. Other slides were exposed to paraformaldehyde vapors in vucuo at 80°C for 2 hours, demyelinated through ascending concentrations of ethanol, xylenes, and descending concentrations of ethanol, dried, and coated, under safelight i~umination, with liquid emulsion (Kodak NTB2, diluted 1: 1 with 0.1% Dreft detergent) [22] . The emulsion-coated sections were exposed in light-proof boxes for 8-16 weeks at 4°C and then developed in D-19 for 2 minutes at 16"C, rinsed in water for 15 seconds, fixed in Rapidfix for 3 minutes, rinsed in water for 45 minutes, counterstained lightly with cresyl violet, and coverslipped in Permount. These sections were compared, using darkfield optics, to adjacent or nearby sections which had been processed for immunocytochemistry. 85-90% specific binding of the tritiated peptide in unfixed rhesus monkey brain sections (data not shown). Binding of [3H] bremazocine to both fixed and unfixed rhesus monkey brain sections was 90-9551 specific. To examine the K selectivity of this binding, competition studies were carried out with UM-1071 (MR 2034), a potent K agonist, and morphine, the prototypical t.& agonist (Fig. 1) . Under the conditions used, UM-1071 was three orders of magnitude more potent than morphine (I&=2.4 nM and 2.2 PM, respectively) in competition with ["Hlbremazocine binding to fixed rhesus monkey brain sections
The LKB Ultrofilm and Kodak wet emulsion autoradiographic methods gave the same results for f3H]naloxone localization, as reported before for rat brain [22, 42] . However, bound ["Hlbremazocine was not successfully vapor-fixed (see [35] ), and was therefore localized using only Ultrofilm.
The anatomical loci of [3H] naloxone and [3H]bremazocine binding sites, using the incubation conditions described, were indistinguishable at every level of the central nervous system which was examined (e.g., Fig. 2 ). Thus, in the following anatomical descriptions, these sites are referred to as opioid binding sites.
The anatomical distribution of opioid binding sites is particularly pronounced in brain regions which also contain subst~ti~ amounts of opioid immunore~tive structures [ 17, 25, 261. As an exception, however, the cerebral cortex and hippocampusldentate gyrus contain a readily visualized population of opioid binding sites (Fig. 6 ), but very little or no apparent opioid immunoreactive perikarya or fibers. In the striatal complex, distinct patches of [3H] opioid binding sites are seen scattered throughout the caudate (Fig. 2) . Both enkephalin and dyno~hin immunorea~tivity also exist in neuronal perikarya as well as fibers in caudate. Furthermore, POMC-immunoreactive fibers are seen in the rostral-ventral aspect of the head of caudate and putamen. The exact anatomical relationship of these opioid systems to opioid X04 receptors is not clear at preseennt, and as is the case in the rat brain 1401, no apparent correspondence is noted between receptor localization and peptide distribution. Enkephalin and dynorphin perikarya in caudate may project to the globus palhdus and the substantia nigra in monkey as they do in rat [71] , but only modest levels of [3H] opioid binding sites are present in either of the latter two regions. Elsewhere in the telencephalon, the bed nucleus of stria terminalis contains a dense concentration of POMC fibers, enkephalin perikarya and terminals, and ["Hlopioid binding sites (Fig.  3) . Furthermore, in amygdala, the central and medial nuclei receive POMC projections, and contain enkephahn and dynorphin perikarya and fibers. Dense [DH]opioid binding is also seen in all regions of the amygdala.
. In the preoptic area, the location of ["Hlopioid binding sites (Figs. 3 and 4) corresponds to the distribution of a distinct bundle of immunoreactive POMC fibers coursing through this region. Numerous enkephalin and dynorphin neuronal perikarya and terminals also are seen scattered in the medial preoptic area.
Within the diencephalon, a particularly good correspondence can be seen between opioid peptides and binding sites (Figs. 4 and 5 Here also, a particularly rich network of enkephahn and POMC terminals is seen surrounding the portal capillaries (Fig. 5) . Opioid binding is also heavy in the magnocellular paraventricular (Fig. 4) and supraoptic (Fig. 2) nuclei, as well as periventricular and infundibaular nuclei (Fig. 4) . The magnocellular nuclei contain high quantities of dynorphin (Fig. 2) synthesized by the same neurons that also produce vasopressin [74] . These cells may also contain Leu-enkephalin; however, the biosynthetic source of this peptide in the magnocellular neurons is not clear at present. The paraventricular, and to a lesser extent, the supraoptic nucleus, are both innervated by POMC fibers. The infundibular nucleus is very rich in both POMC perikarya and fibers (Fig. 4) . This region also contains scattered enkephalin and dynorphin neurons some of which may contribute fibers to the median eminence. In contrast, the lateral and posterior hypothalamic areas contain both lower levels of opioid peptides and ["Hlopioid binding sites. In the thalamus, many nuclei are rich in [3H] opioid binding sites, and most of these nuclei also contain enkephalin immunoreactivity.
The correspondence is particularly striking in the midline periventricular nucleus, which exhibits a dense accumulation of both binding sites as well as POMC and enkephalin fibers (Fig. 5) .
In the region of midbrain, the interpeduncular nuclear complex contains a very dense population of [JH]opioid binding sites (Fig. 3) . This nucleus also contains scattered enkephalin immunoreactive perikarya and fibers, yet is virtually devoid of any POMC immunoreactivity. Dorsally in midbrain, there is a clear correspondence in the relative densities of opioid binding sites and opioid immunoreactivity in the substantia grisea centralis (or periaqueductal gray). Here also, a distinct projection of POMC fibers is seen surrounding the cerebral aqueduct (Fig. 3) .
In the brainstem, the parabrachial nucleus is richly innervated by POMC and enkephalin fibers and terminals and contains a high density of opioid binding sites. Other pontine nuclei and regions are apparently devoid of opioid peptides and binding sites. In the medulla, a good correspondence Results) , but not at all to this structure in human brain 1461.
The apparent colocalization of g and K opioid receptors throughout rhesus monkey brain is in contrast to the differential distribution of apparent JL and 6 opioid receptors in monkey cerebral cortex [41] . A similar pattern also holds for rat brain [ 15, 42, 591. We were unable to examine the distribution of 6 opioid receptors in the present study since virtually all ["HID-Ala*, D-Leu"-enkephalin binding was abolished by formaldehyde perfusion. This fixation-induced loss of S binding was also observed for rat brain [40] . and may be indicative of a chemical difference in the opioid receptor subtypes [23] or possibly a shift in receptor conformation [4, 5] , possibilities which we cannot presently discriminate.
The layer VI (arrow points to area TE, visual as~otl cortex), -, preaubhIum and subiculum, as well as stratum granulosum (e) and stratum moleculare (m) of the dentate gyrus. [73] . The preservation of the anatomical distribution of [3H] naIoxone and 13H]bremazocine binding sites following formaldehyde perfusion has allowed us to perform receptor autoradiographic and opioid peptide immunocytochemical studies on adjacent sections from the same bmin. Although general anatomical relationships between endogenous ligands and receptors can be discerned by comparing tissue sections from brains processed differentially for immunocytochemistry and autoradiography [69.70] . such comparisons are difficult due to problems in section alignment, the complexity of receptor distribution, and the anatomical relatedness of the multiple opioid systems in many regions.
Using adjacent section analysis. we have detected associations between apparent multiple opioid receptqrs and one. two, or all three opioid systems in many regions of rhesus monkey brain [39] . The neural systems involved in the processing of painful stimuli [ 1, 3, 36] provide a good example of these multiple associations. The spinal trigeminal nucleus, the rostra1 continuation of the spinal cord dorsal gray, is particularly rich in both enkephalin and dynorphin perikarya and terminals and apparent p and K opioid receptors. These peptide systems and receptors appear thoroughly interdigitated, at least at the light microscopic level. The periaqueductal gray, or substantia grisea centralis. contains substantial enkephalin and POMC (and some dynorphin) immunoreactivity which occurs in complex relation to the multiple opioid receptors.
Stimulation of this region produces profound analgesia in monkeys 147,541 and humans [60.61], and the role of the multiple opioid systems and receptors in mediating antinociception requires further study. Thalamic nuclei involved in pain processing (e.g., midline periventricular nucleus) also show a correspondence between FQMC and enkephalin immunoreactivity and apparent p and K opioid receptors. While much attention has been focused on the role of p receptors in mediating opioid analgesia, K agonists also have significant antinociceptive actions, though apparently on different types of pain 16, 19, 55. 67, 681. It is also worth noting that /* and K ligands produce centrally discriminable effects in rhesus monkeys [20, 80] . Given the apparent colocahzation of p and K opioid receptors in the species used in the antinociception tests (rats) and drug discrimination paradigms (rhesus monkeys), the behavioral differentiation of p and K effects has interesting implications. These opioid receptor subtypes, although colocalized at the light microscopic level, may have different synaptic loci (e.g., pre-vs. post-vs. non-synaptic) which would determine their actions. This question can perhaps be explored to some extent by electron microscopic localization of opioid receptors [ 181. Still another possibility for c(-K differentiation is at the level of receptor-effector relationships [4. 50. 781.
Despite the close correspondence of opioid peptides and receptors in many areas, there is no apparent relationship in other regions (see also [37, 40] The purpose of the studies described here was to determine whether the anatomical relationship of opioid peptide systems and receptors was related to peptide-receptor affinities in vitro. The complexity of the association between the multiple opioid systems and apparent p and K opioid receptors evidently precludes a straightforward one-to-one view of opioid peptide-receptor relationships.
Thus. the anatomical associations predicted by i/r l*itro receptor studies (e.g., enkephalin-6 or dynorphin-rc) are too simplistic. Indeed, the prediction itself was too simplistic, since it is now known that the dynorphin and enkephalin precursors can give rise to a diversity of opioids with widely differing receptor selectivities. For example, some extended proenkephalin peptides have p and K activity [57] , while the K selectivity of dynorphin A is lost upon COOH-terminal cleavage [9, 57] . Since differential processing of proenkephalin and prodynorphin can give rise 10 opioids of varying receptor selectivities. the colocalization of opioid receptor subtypes may signify that such processing is a key regulatory event in determining which receptor subtype is activated and, thus, the physiological consequences of opioid neurotransmission. 
